Syon Capital LLC Novavax Inc Transaction History
Syon Capital LLC
- $1.11 Trillion
- Q4 2024
A detailed history of Syon Capital LLC transactions in Novavax Inc stock. As of the latest transaction made, Syon Capital LLC holds 15,960 shares of NVAX stock, worth $127,520. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,960Holding current value
$127,520% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
93.8MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$126 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$94.7 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$89.1 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$61.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$46.3 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $625M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...